Pristiq Approval History
FDA Approved: Yes (First approved February 29, 2008)
Brand name: Pristiq
Generic name: desvenlafaxine
Dosage form: Extended-Release Tablets
Company: Wyeth Pharmaceuticals
Treatment for: Depression, Major Depressive Disorder
Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment for adult patients with major depressive disorder. Pristiq is also currently under review as a treatment for moderate-to-severe vasomotor symptoms associated with menopause.
Development History and FDA Approval Process for Pristiq
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.